이슬기 (Johns Hopkins University School of Medicine)님 | 한빛사연구자 > 한빛사

Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of scleroderma

Nat. Commun., Published 08 March 2019, 10, Article number: 1128 | https://doi.org/10.1038/s41467-019-09101-4

Protease-Activated Drug Development

Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease

Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells

Hepatology, Accepted manuscript online: 28 December 2015 | DOI: 10.1002/hep.28432View/save citation

Polysaccharide-based nanoparticles for theranostic nanomedicine

Adv. Drug Deliv. Rev., Volume 99, Part A, 1 April 2016, Pages 70-84, doi:10.1016/j.addr.2015.11.015

Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives

Mix to Validate: A Facile, Reversible PEGylation for Fast Screening of Potential Therapeutic Proteins In Vivo

Angew. Chem.-Int. Edit., Article first published online: 5 JUN 2013 | DOI: 10.1002/anie.201302181

A Facile, One-Step Nanocarbon Functionalization for Biomedical Applications

Multiplex Imaging of an Intracellular Proteolytic Cascade by using a Broad-Spectrum Nanoquencher

Angew. Chem.-Int. Edit., Article first published online: 2 JAN 2012 | DOI: 10.1002/anie.201107795

High-sensitivity nanosensors for biomarker detection

Chem. Soc. Rev., 2012, 41, 2641-2655 | First published on the web 20 Dec 2011 | DOI: 10.1039/C1CS15238F

저자논문